BERLIN — At 8 p.m. Sunda, the phone rang with the call Ugur Sahin, chief executive of the German medical startup BioNTech, had been anxiously awaiting. “Are you sitting down?” Pfizer chief Albert Bourla asked him. The news that followed was better than Sahin had hoped: Preliminary analysis from Phase 3 trials of his company’s […]
source https://www.seattletimes.com/nation-world/this-modest-german-turkish-couples-coronavirus-vaccine-candidate-has-made-them-billionaires/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment